Dáil Éireann Debate, Wednesday - 16 November 2016
180. Deputy Alan Kelly asked the Minister for Health the way in which the HSE charges and calculates rebates for biosimilar drugs that are approved and for sale in the market; and if he will make a statement on the matter. [35288/16]
Amharc ar fhreagraDetails of the level of rebates and medicines to which it applies are set out in the new Framework Agreement on the Supply and Pricing of Medicines 2016-2020. The Agreement is available at:
http://health.gov.ie/blog/publications/framework-agreement-on-the-supply-and-pricing-of-medicines/.
The issue in relation to the calculation of the rebate by the Primary Care Reimbursement Service and hospitals has been referred to the HSE to respond directly to the Deputy as this is an operational matter.
